genae Receives Investment from Korys

genaegenae, an Antwerp, Belgium-based global Contract Research Organization (CRO) and services provider for the medical industries, received an investment from Korys.

The amount of the deal was not disclosed.

The company will use the funds to accelerate development and further strengthen its market position in Europe, the US and Japan.

Led by Bart Segers, CEO, genae is a full service CRO and services provider for the medical industries.
The company offers clinical research services including project management, site management, site selection, auditing and monitoring; regulatory & safety services including submissions, AE reporting, DSMB / CEC, reimbursement, legal representation and Trial design; and e-solutions including data management, statistics and electronic data tools.

Led by Vincent Vliebergh, CEO, Korys is the investment holding of the Colruyt family which aims to create a diversified portfolio of investments focusing on sectors such as Consumer and Retail, Renewable Energy and Life Sciences.



Join the discussion